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Abstract
AIM
To compare (1) quality of life and (2) rate of recurrent 
small bowel obstructions (SBO) for patients treated 
with novel manual physiotherapy vs  no treatment. 
METHODS
One hundred and three subjects (age 19-89) with a 
history of recurrent adhesive SBO were treated with a 
manual physiotherapy called the Clear Passage Approach 
(CPA) which focused on decreasing adhesive crosslinking 
in abdominopelvic viscera. Pre- and post-therapy data 
measured recurring obstructions and quality of life, 
using a validated test sent 90 d after therapy. Results 
were compared to 136 untreated control subjects who 
underwent the same measurements for subjects who did 
not receive any therapy, which is the normal course for 
patients with recurring SBO. Comparison of the groups 
allowed us to assess changes when the physiotherapy 
was added as an adjunct treatment for patients with 
recurring SBO.
RESULTS
Despite histories of more prior hospitalizations, ob-
structions, surgeries, and years impacted by bowel issues, 
the 103 CPA-treated subjects reported a significantly 
lower rate of repeat SBO than 136 untreated controls 
(total obstructions P  = 0.0003; partial obstructions P  = 
0.0076). Subjects treated with the therapy demonstrated 
significant improvements in five of six total domains in the 
validated Small Bowel Obstruction Questionnaire (SBO-Q). 
Domains of diet, pain, gastrointestinal symptoms, quality 
of life (QOL) and pain severity when compared to post 
CPA treatment were significantly improved (P < 0.0001). 
The medication domain was not changed in the CPA 
treated group (P = 0.176).
CONCLUSION
CPA physical therapy was effective for patients with 
adhesive SBO with significantly lower recurrence rate, 
improvement in reported symptoms and overall quality 
of life of subjects.
Key words: Clear passage approach; Manual therapy; 
Physical therapy; Small bowel obstructions; Adhesions; 
Physiotherapy; Alternative therapy
© The Author(s) 2018. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: A manual soft tissue physical therapy protocol 
is an effective low risk preventative treatment option 
for patients who suffer recurrent adhesive small bowel 
obstructions. It increased the quality of life of subjects 
by decreasing pain, decreasing recurrent obstructions, 
improving diet and increasing bodily function. Because 
the therapy was performed in an outpatient setting, it 
eliminated the need for hospitalization and the risk and 
increased cost of surgery.
Rice AD, Patterson K, Reed ED, Wurn BF, Robles K, 
Klingenberg B, Weinstock LB, Pratt JS, King CR, Wurn LJ. 
Decreasing recurrent bowel obstructions, improving quality of 
life with physiotherapy: Controlled study. World J Gastroenterol 
2018; 24(19): 2108-2119  Available from: URL: http://www.
wjgnet.com/1007-9327/full/v24/i19/2108.htm  DOI: http://dx.doi.
org/10.3748/wjg.v24.i19.2108
INTRODUCTION
Adhesive small bowel obstruction (SBO) is a common 
life-threatening complication of surgery or abdominal 
trauma in both pediatric and adult populations, typically 
caused by adhesions that form as a normal part of the 
healing process[1-3]. As a side effect of the inflammatory 
response required for healing to occur, adhesions form in 
tissues at and near the surgical repair within hours, due 
to the presence of collagen and scar tissue mediators. 
Surgery is frequently cited as the primary cause of 
adhesive bowel obstruction; repeat surgery increases 
the risk of adhesion formation[4]. The financial cost 
per patient for adhesiolysis and bowel resection was 
$65955 and $114175, respectively, with 30-d hospital 
readmission rates of 12.3% and 18.1% in the United 
States in 2010[5]. The average hospital stay for cases of 
SBO surgery was 14.2 d, and for abdominal adhesiolysis 
was 8.4 d[5]. 
The present cost of a one-week course of CPA 
physical therapy is under $7000 in the United States 
(and is comparable in the United Kingdom). The therapy 
is performed in an outpatient setting; no hospitalization 
or surgery is required.
A large previously published clinical study that 
followed adult subjects 10 years post-surgery found that 
more than 30% of the surgical small bowel resection 
subjects underwent additional surgery due to adhesions 
within the study time frame[6]. In a prospective analysis 
of patients undergoing laparotomy who had previously 
had one or more abdominal operations, 93% (195/210) 
were found to have adhesions attributable to their prior 
surgery[1]. Patients with mesh inserted during surgery 
have been identified as having an increase in adhesion 
formation, leading to increased complexity of future 
surgical procedures[7-9]. 
Thus, adhesion related disease causes significant 
surgical efforts, hospital resources and comprises 
major expenditures each year. Additionally, there is a 
considerable negative impact on the patients’ quality of 
life (QOL).
In the absence of bowel ischemia, strangulation or 
perforation, current guidelines for the management of 
SBO are gastric decompression with suction, full strength 
gastrographin (in some institutions), and IV hydration 
for the first 24-72 h to see if the obstruction will resolve 
without surgery[10]. While sometimes effective in treating 
the current obstruction, this approach does not address 
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the internal adhesions or the risk of subsequent bowel 
obstructions[11,12]. The only treatment currently available 
to reverse adhesive bowel obstructions is surgery, which 
frequently causes new adhesions. A number of surgical 
techniques, modifications, and adhesion preventing 
medications and barriers have been investigated, but 
no solution has been shown to significantly prevent the 
formation of adhesions to date[13-19]. Thus, any therapy 
that decreases the risk of bowel obstruction in the 
absence of surgery is of significant importance.
Manual physical therapy (mPT), a method of physio-
therapy and rehabilitation, is used to treat patients with 
a wide variety of adhesive conditions including burns, 
adhesive capsulitis, radiculopathy, pain, infertility, and 
lessening of scars[20-30]. This therapy has shown promise 
in preventing adhesion formation in animal models[31,32]. 
The Clear Passage Approach (CPA), a specialized 
mPT regimen, hypothesized to deform the adhesions 
that cause SBO episodes, has been demonstrated as 
effective in decreasing adhesions, pain, and improving 
QOL in subjects with recurrent SBO in case control 
and efficacy studies[33-35]. In pilot studies, independent 
radiologic reports showed that the therapy cleared 
bowel stricture and obstruction, obviating the need for 
planned laparotomy for adhesiolysis and SBO[36,33-35].
Surgery is often necessary in cases of bowel ob-
struction complicated by ischemia or caused by hernia or 
cancer, however surgery has not been shown to improve 
quality of life (QOL), reduce pain or recurrence rate in 
patients with adhesive SBO. Further, except as shown in 
pilot studies of CPA therapy, there is currently no other 
treatment available to patients with known adhesions 
who are currently not obstructed to reduce recurrence, 
pain or need for further surgery. In this study, we report 
on the use of the CPA, a manual physical therapy 
protocol, to treat abdominal and pelvic adhesions that 
cause SBO, and to improve the quality of life (QOL) of 
study subjects when compared to untreated subjects in a 
control arm. 
Aim and hypothesis
The aim of the study is twofold: (1) To determine whe-
ther a manual physiotherapy can lower the rate of repeat 
SBO in patients who have undergone prior adhesive 
bowel obstructions and surgeries, and (2) to examine 
whether the therapy can improve the quality of life of 
these patients, using a validated test.
The hypothesis is that the manual physiotherapy 
treatment can decrease SBO recurrence and improve the 
self-reported quality of life in subjects with a history of 
adhesive SBO, compared to untreated control subjects.
MATERIALS AND METHODS
Eligibility criteria
Subjects in the retrospective CPA treatment arm were 
selected for inclusion in the study based upon medical 
history and completion of both a pre-treatment and 
post-treatment questionnaire. Only adult subjects were 
included in this study. Exclusion criteria included: BMI 
> 36, active infection, abnormal ovarian cysts, surgery 
within the last 90 d, and bleeding disorders. Each 
subject was provided with a written informed consent 
as is standard for the clinical practice. Subjects with a 
recent history of cancer were excluded from this study. A 
total of 103 subjects were treated at one of five private 
physical therapy clinics affiliated with Clear Passage 
between November 2012 and October 2015. All CPA 
therapists and affiliates completed 80 h practical training 
and evaluation course prior to becoming certified in the 
Clear Passage Approach. All subjects with follow up were 
eligible and included in the analysis.
Subjects in the control arm were recruited via web-
site and online advertisements for the study. Inclusion 
criteria included: adult subjects who had experienced a 
partial or total bowel obstruction within the last two years. 
Exclusion criteria included: Cancer within the last 5 years, 
chemotherapy or radiation treatments in the last 10 years, 
current pregnancy, or prior treatment at Clear Passage. 
All study related activities were performed via the NIH 
Assessment Center (www.assessmentcenter.net) including 
screening, informed consent and all data collection. A total 
of 460 subjects were screened, with 281 subjects eligible 
and 260 completing the initial questionnaire; 6 subjects 
were removed from the control study due to having pre-
viously received CPA treatment, 117 subjects were lost to 
follow up, 1 subject was removed due to less than 50% 
of the follow up questionnaire being completed. A total 
of 136 subjects completed both questionnaires and were 
included in the analysis. The study diagram is shown in 
Figure 1. This study was approved by MaGil Institutional 
Review Board.
Study design
This was a non-randomized controlled study comparing 
subjects with a history of SBO that underwent CPA 
treatment to that of untreated control subjects. The CPA 
treatment group included a retrospective chart review 
of subjects treated for adhesive disease with a history 
of SBO that had undergone standard clinic follow up. All 
subjects included in the treatment arm received treatment 
within private outpatient physical therapy clinics by 
therapists certified in the CPA. Subjects in a prospective 
untreated control arm, including those not treated with 
the CPA, were recruited for participation in a survey based 
observational data collection.
Outcomes were measured via an observational 
manner using the validated paper based SBO Question-
naire (SBO-Q) using previously established quartiles[37]. 
The SBO-Q was developed and validated to be used 
as a patient reported tool to quantify the experiences 
of patients with recurrent SBOs. The questionnaire is 
comprised of five domains and a pain rating section. 
Each domain measures a distinct aspect of QOL. The Diet 
domain assesses the diet of the subject from inability 
to tolerate any liquid to a normal solid food diet. The 
Pain domain reported pain throughout the body, with 
oral intake of food or liquid, and with bowel function. 
2110 May 21, 2018|Volume 24|Issue 19|WJG|www.wjgnet.com
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significant difference of 1 point in the mean domain 
score of two domains. All computations were made in 
the statistical software R[38].
Treatment
Subjects treated with the CPA received manual therapy 
to areas of the body identified by the treating therapists 
as showing decreased mobility or function during the 
evaluation via palpation and range of motion tests. 
All subjects were evaluated from head to toe. In the 
case of these subjects the focus of the therapy was 
to the abdominopelvic viscera that demonstrated de-
creased mobility, hypothesized to be due to adhesions 
formed after surgery, trauma, or other tissue damage, 
therefore leading to SBO episodes. The majority of the 
therapy focused on treating abdominopelvic viscera 
that demonstrated decreased mobility with palpation. 
Treatment was administered in multiple hour sessions, 
which included up to four hours a day over the course of 
5 d with the typical subject completing 20 h of treatment. 
The average number of treatment hours per subject was 
22.6 ± 8.5 h with a range of 10-74 h; 75 of 103 subjects 
in CPA treatment group received 20 h of treatment.
In order to decrease adhesions, the CPA uses 
techniques from a variety of manual modalities to treat 
the subject in an individualized manner, focusing on 
each subjects’ areas of restriction and concern with the 
goal of deforming adhesions and increasing the mobility 
of adhered tissues and organs, working from the most 
superficial tissues to those deeper in the body. The 
therapy accomplishes this by the use of various site-
specific pressures across restrictive bands of adhered 
tissues and structures within the abdomen and pelvis, 
using a bimanual deep massage. The intent of the 
therapy is to detach and reverse the crosslinking that 
The Gastrointestinal (GI) Symptom domain quantifies 
symptoms often associated with SBO such as nausea, 
emesis, bowel spasm and constipation. The Medication 
domain reports the frequency of medications required 
to maintain bowel function. The QOL domain quantifies 
the amount of time off work, social activities and overall 
concern of the patient regarding their bowel function. 
These tend to be major lifetime concerns for many people 
who experience recurring bowel obstructions.
Subjects provided previous medical history and 
records; no radiologic evaluations were performed as 
a part of the study. Questionnaires were completed 
prior to treatment for the control measure. The post-
treatment questionnaires were sent to the subjects 90 
d post-treatment, with completion at 78-140 d post-
treatment for the CPA treatment arm and 90-115 d for 
the control arm subjects. 
Sample size calculation
For evaluating the power of our study, we made some 
simplifying assumptions. We assumed that differences 
in the 6 domain scores before and after treatment 
follow a normal distribution. For all but two of the 
SBO-Q domains we assumed that the mean difference 
was zero (i.e., no treatment effect), but for two domains 
we assumed that the treatment lowered the average 
domain score by 1 point. We assumed that the standard 
deviation of each difference was 2.5 points. We then 
simulated the power by looking at the proportion of 
times that both multiplicities adjusted two-sided P-values 
for the two domains where we assumed a treatment 
effect is less than 5%. When selecting a sample size 
of 100, this was the case in 82% of our simulations. 
Therefore, 100 patients in the pre- and post-treatment 
comparison result in at least 80% power to detect a 
Figure 1  Study diagram.
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binds collagenous fibers together to form adhesions. 
The therapists work progressively deeper from the 
most superficial tissues restoring mobility via myofascial 
release[39]. Adhesions within and between organs and 
interstitial spaces within the viscera were addressed 
using the Wurn technique[29,34] which is a bimanual soft 
tissue manipulation that can include a slow stretch to 
adhered areas within the abdomen and pelvis, previously 
shown to return patency to occluded fallopian tubes. The 
intent of this technique is to detach crosslinks that bind 
collagen fibers, thus shearing apart adhesions manually, 
in order to return the tissues to a more mobile, less 
adhered state. Toward the end of deep tissue work, CPA 
certified therapists may use visceral manipulation to 
increase organ motility[39]. The amount of force and time 
the force was applied to each area has the potential to be 
significant but was maintained within the tolerance of the 
subject in accordance with guidelines of the American 
Physical Therapy Association. Detailed clinical treatment 
records were maintained throughout the course of 
therapy.
Subject monitoring
Subjects enrolled in the control arm of the study were 
not monitored as this was an observational web-based 
study arm. Subjects included in the treatment arm 
were monitored daily for changes in pain, diet, bowel 
habits and overall well-being during their treatment as 
is standard practice. Adverse events were monitored by 
the treating therapists during the course of treatment 
and reviewed during the chart review process. There 
were no adverse events reported in the CPA treated 
group within the clinical data, or by follow up.
Disease scoring
The overall degree of adhesive disease was determined 
using a clinic generated disease scoring table that takes 
into account all qualitative and quantitative measures 
performed during the initial evaluation and post treatment 
discharge assessment. The degree of impact on a subject’
s quality of life for range of motion was determined using 
multiple resources, as well as the extensive experience 
of the therapists. Multiple other standard physiotherapy 
tests were also performed and included in the assessment 
for disease score[40-44]. Supplemental Table 1 contains the 
disease scoring protocol in which the score is expressed as 
a decimal in which 0 represents no disease or impact on 
overall function and 1 is severely impacted.
Statistical analysis
We used χ 2 tests and t-tests for the analysis comparing 
the demographic and medical variables between the 
treated and control group. 
For analyzing the multivariate responses from the 
SBO-Q we used the minimum P-value based on a paired 
t-statistic for each survey question as the test statistic for 
the overall and the domain hypotheses[45]. The raw and 
multiplicity adjusted P-values displayed in tables refer 
to testing the null hypothesis that the mean difference 
between the initial and follow-up survey equals 0. Since 
there are 6 domains for which we tested for a mean 
difference, we used multiplicity adjusted P-values to 
adjust the raw P-values and account for the fact that 
we are testing 6 hypotheses simultaneously. For a 
particular domain, a significant difference in the mean 
domain score can be concluded when the corresponding 
multiplicity adjusted domain P-value is less than 0.05. 
Table 1  Demographics
Characteristics Control CPA treatment P  value
Age, yr
   Median      33.5 57 < 0.001
   Range 19-71 19-89
Sex
   Male   58 33 0.0853
   Female   78 70
Race
   White   80 90
   Black/African American   39   1
   American Indian/Alaska Native     1   2
   Asian     3   2
   Native Hawaiian/Pacific Islander     0   0
   Other   11   0
   Unknown     2   8
Ethnicity
   Hispanic or Latino   12   1
   Not Hispanic or Latino 108 91
   Unknown   16 11
Marital Status
   Married/long term relationship   47 69
   Single   63 16
   Divorced/widowed   25 11
   Unknown     1   7
CPA: Clear Passage Approach.
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Using the multiplicity adjusted P-values (computed via the 
Bonferroni correction) will control the overall (familywise) 
error rate at 5%. Similarly, the multiplicity adjusted 
P-values for each survey question account for the fact 
that we are testing 37 hypotheses comparing mean 
differences simultaneously, one for each question. For 
any given survey question, a multiplicity adjusted P-value 
less than 0.05 implies a significant difference in the mean 
score, controlling the overall rate of Type I errors at 5% 
when testing these 37 hypotheses simultaneously.
The statistical package R (R Foundation for Statistical 
Computing, Vienna, Austria) was used for all statistical 
analyses.
RESULTS
A total of 103 CPA treated subjects and 136 untreated 
control subjects were included in the analysis. Demo-
graphics for study subjects are located in Table 1 and 
number of prior surgeries and bowel obstructions are 
located in Table 2. Subjects in the CPA treatment group 
were significantly older, and the total numbers of prior 
surgeries, partial SBOs, and years impacted with bowel 
symptoms were much higher than that of the control 
group. There were 46.2% male subjects in the control 
group and 32% male subjects in the CPA treated 
group (P = 0.0853). The average age of subjects in 
the control group was 36.4 ± 12.5 years and 54.5 ± 
15.7 years for the CPA treated group (P < 0.001); the 
average number of prior surgeries in the control is 2.07 
± 1.29 as compared to 4.56 ± 2.86 for the CPA treated 
(P = 0.0001). The average number of prior partial SBOs 
in the control group was 1.88 ± 1.60 and 3.97 ± 5.09 
in the CPA treated group (P = 0.0001). The number of 
total SBO was 2.17 ± 1.85 for the control group and 1.68 
± 7.95 for the CPA treated group (P = 0.4894). The 
number of years the subjects reported bowel symptoms 
impacted their lives was 5.5 ± 7.2 for the control group 
and 10.7 ± 11.2 for the CPA treated group (P < 0.001).
Rates of recurrent SBO
All subjects at the 90-d follow up questionnaire were 
queried regarding the numbers of bowel obstructions, 
hospitalization, and surgery for SBO experienced. 
There were differences between the groups, with the 
CPA treated group reporting fewer total number of 
obstructions, hospitalizations and surgeries. A total of 
124 control and 103 CPA treated subjects responded to 
the questions. 21.77% of the control group subjects and 
8.74% of the CPA group subjects experienced a partial 
bowel obstruction between the two questionnaires (P = 
0.0076), 14.52% of control group subjects and 0.97% 
of CPA group subjects reported a total bowel obstruction 
(P = 0.0003), 5.65% of control group subjects and 
1.94% of CPA group subjects reported undergoing 
surgery for a bowel obstruction (P = 0.1548). The 
differences between untreated and treated patients 
at follow up would naturally extrapolate into a sizable 
decrease in cost, due to avoiding repeat SBO-related 
hospitalizations and surgeries. 
SBO-Q analysis
For both the control and CPA group we tested the null 
hypothesis that for each of the 6 domains the mean 
domain score the first time the survey was administered 
was equal to the mean domain score the second time 
the survey was administered 90 d later. The alternative 
hypothesis was that there was a significant difference in 
the mean domain score between the initial and follow-
up administration of the survey for at least one domain. 
Missing data from any question/subject was removed 
from the overall analysis.
For the control group data, despite the fact that no 
intervention took place between the two times the survey 
Control CPA treatment P  value
Number of previous surgeries
   0     4   4 < 0.001
   1-2   89 16
   3-5   39 34
   > 6     3 49
   unknown     1   0
Number of prior partial bowel obstructions in the last 3 yr < 0.001
   0     3 24
   1-10 132 70
   11-20     1   8
   > 20     0   1
Number of prior total bowel obstructions      0.4894
   0     4 53
   1   47 29
   2   46 11
   3   27   3
   4 or more   12   7
Number of years impact on life due to bowel issues
   Average (SD) 5.5 (7.2) 10.7 (11.2)   < 0.0001
Table 2  Medical history
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was administered, Table 3 shows a significant difference 
(multiplicity adjusted P < 0.05) in mean domain scores for 
the Pain and GI Symptoms domain. However, the lower 
bounds of a corresponding confidence interval for the 
mean difference in domain scores are close to zero (0.02 
and 0.05, respectively), indicating that, while statistically 
significant, the actual improvement may be very small. 
A further analysis of the individual survey questions 
shows that within the Pain domain, General, Lower GI, 
BM and Eating pain improved significantly between the 
initial and follow-up survey. However, note the small 
lower bounds for the corresponding confidence intervals 
for the mean difference, indicating very small changes 
except perhaps for BM and General pain. The significant 
improvement in those two could reflect a time-effect, the 
perceived pain lessening over time. Similarly, the three 
significant differences for individual questions in the GI 
Symptoms domains all have very small lower bounds of 
corresponding confidence intervals. For all other domains 
and all other individual survey questions within domains 
no significant differences emerged (multiplicity adjusted 
P-values > 0.05). The diet domain had multiplicity 
adjusted P = 0.425, the Medication domain P = 0.804, 
and the QOL domain P = 0.126, all indicating no major 
changes in symptoms over the three-month period studied.
For the CPA group, Table 4 shows significant diffe-
rences for all domains (multiplicity adjusted P-value < 0.05) 
except for the Medication domain (multiplicity adjusted 
Table 3  Average difference (before/after) in Small Bowel Obstruction Questionnaire scores and P -values for each domain and 
question for the control group
Domain question Difference mean, St. Dev Raw P -value Multiplicity adjusted P -value Lower confidence bound Upper confidence bound
Diet -0.06 0.93 0.425 1.000 -0.28 0.15
   Liquid -0.09 1.08 0.342 1.000 -0.39 0.21
   Soft -0.20 1.20 0.055 1.000 -0.54 0.14
   Solid -0.11 1.48 0.388 1.000 -0.53 0.31
   Anything  0.13 1.35 0.256 1.000 -0.25 0.51
Pain1  0.17 0.61 0.002 0.013  0.02 0.31
   General2  0.50 1.23 0.000 0.000  0.15 0.85
   Upper GI  0.00 1.11 1.000 1.000 -0.31 0.31
   Lower GI2  0.35 1.14 0.000 0.016  0.03 0.67
   BM2  0.50 0.96 0.000 0.000  0.23 0.77
   Head_neck  0.01 1.05 0.935 1.000 -0.29 0.30
   Migrane  0.05 1.18 0.612 1.000 -0.28 0.38
   Coccyx -0.13 1.07 0.150 1.000 -0.43 0.17
   Eating2  0.35 1.24 0.001 0.045  0.00 0.70
   Drinking  0.02 1.10 0.815 1.000 -0.29 0.33
   Back  0.01 1.11 0.877 1.000 -0.30 0.33
GI symptoms1  0.18 0.58 0.000 0.003  0.05 0.32
   Nausea  0.29 1.22 0.006 0.215 -0.05 0.64
   Vomit -0.04 0.88 0.627 1.000 -0.28 0.21
   GI_spasm -0.01 0.97 0.860 1.000 -0.29 0.26
   Constipation  0.06 0.90 0.448 1.000 -0.19 0.31
   Diarrhea  0.26 1.14 0.010 0.354 -0.06 0.58
   BS_JLM  0.04 0.96 0.592 1.000 -0.22 0.31
   Gas_bloat_dist2  0.39 1.32 0.001 0.028  0.02 0.76
   Inc_sounds2  0.41 1.14 0.000 0.002  0.09 0.73
   No_BM  0.07 1.10 0.437 1.000 -0.24 0.38
   Ab_BM  0.01 1.22 0.889 1.000 -0.33 0.36
   Eat_bloat2  0.45 1.51 0.001 0.025  0.03 0.88
Medication -0.03 1.39 0.804 1.000 -0.35 0.29
   Meds -0.03 1.39 0.804 1.000 -0.42 0.36
Quality of life  0.10 0.77 0.126 0.759 -0.08 0.28
   Off_work  0.13 1.19 0.218 1.000 -0.21 0.46
   Off_social  0.10 1.42 0.396 1.000 -0.30 0.50
   Off_sex  0.12 1.37 0.313 1.000 -0.27 0.51
   Off_daily_function  0.25 1.38 0.036 1.000 -0.14 0.64
   Off_eat_out  0.34 1.23 0.002 0.059 -0.01 0.69
   Massage_worry -0.31 1.19 0.003 0.104 -0.65 0.02
   Worry  0.06 1.07 0.521 1.000 -0.24 0.36
Pain severity  0.23 1.46 0.064 0.382 -0.10 0.57
   Duration_pain  0.33 1.24 0.003 0.105 -0.02 0.68
   Recent_max_pain  0.24 2.62 0.295 1.000 -0.50 0.97
   Recent_min_pain  0.35 2.17 0.064 1.000 -0.26 0.96
   Recent_avg_pain  0.02 1.89 0.892 1.000 -0.51 0.55
1Denotes domains for which average scores (over all questions within a domain) are significantly different between the initial and the follow-up survey, 
controlling the familywise error rate (over the 6 domains) at 5%. 2Denotes questions for which scores are significantly different between the initial 
and the follow-up survey, controlling the familywise error rate (over the 37 questions included in the SBO-Q) at 5%. SBO-Q: Small Bowel Obstruction 
Questionnaire.
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P-value = 0.176). The domain confidence intervals 
indicate that the mean difference in the average Diet and 
Quality of Life score falls somewhere in between 0.5 and 
1.0 on the 5-point scale, which is a rather large average 
effect. (For comparison, in the control group, no significant 
differences were reported for these two domains). Further, 
the difference in the average Pain Severity score was 
significant, ranging from 1.07 to 1.95. (For the control 
group, there was no significant difference.) 
Overall, in the CPA group 29 out of 37 survey 
questions showed a significant difference (in fact, im-
provement), compared to just 7 in the control group. 
Judging by the confidence intervals (CIs), some of the 
strongest improvements were seen in the Pain, QOL, and 
Diet domains. In the Pain Domain, notable improvements 
occurred for the questions “Experience of pain in general” 
(CI: 0.43-1.34), “Experience pain in the upper GI region” 
(CI: 0.41-1.29), “Recent Maximum Pain” (CI: 1.62-3.78) 
and “Duration of Pain” (CI: 0.61-1.82).
Patients who have undergone the significant trauma 
of SBO accompanied by long hospital stays (average 14.2 
d[5]), followed by invasive surgeries and recovery from 
those events have significant “QOL” concerns afterwards. 
With regard to the QOL domain, some noteworthy large 
differences between the initial and follow-up survey 
were observed for the question “How often the subject 
worries about another SBO” (CI: 0.78-1.85), “How often 
the subject was unable to perform daily functions” (CI: 
0.53-1.45) and “How often the subject was unable to 
attend social events”, (CI: 0.36-1.21). Related to QOL 
Table 4  Average difference (before/after) in Small Bowel Obstruction Questionnaire scores and P -values for each domain and 
question for the Clear Passage Approach treatment group
Domain question Change mean, St. Dev Raw P -value Multiplicity adjusted P -value Lower confidence bound Upper confidence bound
Diet1 0.77 1.03 0.000 0.000  0.49 1.04
   Liquid2 0.49 1.19 0.000 0.003  0.10 0.87
   Soft2 0.71 1.38 0.000 0.000  0.26 1.16
   Solid2 0.91 1.70 0.000 0.000  0.35 1.47
   Anything2 0.98 1.66 0.000 0.000  0.44 1.53
Pain1 0.52 0.73 0.000 0.000  0.33 0.72
   General2 0.88 1.41 0.000 0.000  0.43 1.34
   Upper GI2 0.85 1.34 0.000 0.000  0.41 1.29
   Lower GI2 0.58 1.49 0.000 0.005  0.10 1.07
   BM2 0.49 1.08 0.000 0.001  0.13 0.85
   Head_neck 0.39 1.39 0.005 0.201 -0.06 0.85
   Migrane 0.11 0.69 0.117 1.000 -0.12 0.34
   Coccyx 0.16 0.75 0.035 1.000 -0.09 0.41
   Eating2 0.68 1.51 0.000 0.001  0.18 1.17
   Drinking2 0.46 1.26 0.000 0.013  0.05 0.87
   Back2 0.59 1.29 0.000 0.000  0.17 1.01
GI symptoms1 0.44 0.68 0.000 0.000  0.26 0.62
   Nausea2 0.53 1.13 0.000 0.000  0.16 0.90
   Vomit 0.17 0.58 0.003 0.113 -0.02 0.36
   GI_spasm 0.20 0.89 0.026 0.979 -0.09 0.49
   Constipation2 0.54 1.48 0.000 0.013  0.06 1.03
   Diarrhea2 0.41 1.19 0.001 0.028  0.02 0.79
   BS_JLM 0.06 1.01 0.559 1.000 -0.27 0.39
   Gas_bloat_dist2 0.72 1.46 0.000 0.000  0.24 1.19
   Inc_sounds 0.37 1.35 0.008 0.286 -0.08 0.81
   No_BM2 0.56 1.36 0.000 0.003  0.11 1.01
   Ab_BM2 0.63 1.54 0.000 0.003  0.13 1.14
   Eat_bloat2 0.71 1.39 0.000 0.000  0.26 1.17
Medication 0.40 1.84 0.029 0.176 -0.09 0.89
   Meds 0.40 1.84 0.029 1.000 -0.20 1.00
Quality of life1 0.78 0.85 0.000 0.000  0.55 1.01
   Off_work2 0.42 0.91 0.000 0.000  0.12 0.72
   Off_social2 0.78 1.29 0.000 0.000  0.36 1.21
   Off_sex2 0.61 1.45 0.000 0.003  0.12 1.10
   Off_daily_function2 0.99 1.40 0.000 0.000  0.53 1.45
   Off_eat_out2 0.64 1.38 0.000 0.000  0.19 1.09
   Massage_worry2 0.75 1.82 0.000 0.003  0.15 1.34
   Worry2 1.32 1.64 0.000 0.000  0.78 1.85
Pain Severity1 1.51 1.66 0.000 0.000  1.07 1.95
   Duration_pain2 1.21 1.86 0.000 0.000  0.61 1.82
   Recent_max_pain2 2.70 3.26 0.000 0.000  1.62 3.78
   Recent_min_pain2 0.65 1.82 0.001 0.023  0.04 1.25
   Recent_avg_pain2 1.20 1.97 0.000 0.000  0.55 1.86
1Denotes domains for which average scores (over all questions within a domain) are significantly different between the initial and the follow-up survey, 
controlling the familywise error rate (over the 6 domains) at 5%. 2Denotes questions for which scores are significantly different between the initial and the 
follow-up survey, controlling the familywise error rate (over the 37 questions) at 5%.
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but analyzed under the Diet domain, the question about 
“The ability to eat anything” also showed some large 
improvements (CI: 0.44-1.53).
When the total number of subjects per SBO-Q domain 
are assessed for both questionnaires for the quartiles 
indicating the degree of impact (normal, mild, moderate 
and severe) it was observed that the general trend 
demonstrated more subjects reporting experiences 
corresponding to no impact or normal for the quartiles in 
the CPA treatment group than the control group (Table 5). 
The significance observed in the individual question score 
analysis is also observed in this representation of the 
data, showing the clinical significance of these changes in 
the CPA treated group.
Trunk range of motion
All CPA treated subjects underwent a comprehensive 
physical therapy initial evaluation that included measure-
ments for range of motion (ROM). It has been previously 
demonstrated that a significant improvement in ROM 
in the trunk was observed in patients with a history 
of SBO and may be a positive predictor for outcome. 
Included in these measurements are: trunk flexion; trunk 
extension; left and right side bending; left and right trunk 
rotation[40,42-44]. 
Every subject who presented with decreased ROM 
demonstrated improvement for at least one of the mea-
surements presented in Table 6. Furthermore, 31.47% of 
total measurements were within the normal range after 
CPA treatment compared to 19.74% before treatment. 
Although not all subjects had a normal ROM for all mea-
sures after treatment, all subjects demonstrated overall 
improvements.
Statistical analysis of changes showed a significant 
increase in the mean ROM after treatment compared to 
before for all six measures (multiplicity adjusted P-values 
< 0.05). 
Patients with a history of SBO and surgery often 
presented with a kyphotic posture; we surmised this was 
due to the pull of abdominal adhesions, creating a forward 
flexion of the trunk. The improvement in trunk extension 
following CPA treatment suggests that adhesions in the 
abdomen and pelvis that prevented the subject from 
bending backwards or standing upright prior to therapy 
diminished enough to show significant improvement in 
trunk extension following the manual treatment. The 
improvements in side bending and rotation also suggest 
that decreasing adhesions in the abdomen and pelvis 
allowed improved trunk ROM. These findings indicate 
that improvements in trunk ROM measurements may be 
suitable as a predictor for degree of adhesion deformation 
post CPA treatment.
Disease scoring
The observations made by the therapists at the initial 
evaluation and after CPA treatment were utilized to 
generate an objective numerical value for analysis of 
the overall state of the adhesive disease of the treated 
subjects. This numerical score takes into account the 
entire patient - assessed from head to toe, and includes 
ROM, organ motility, standard physical therapy tests, 
posture and tissue response with a range from 0 (no 
disease or deficiencies) to 1.0 (maximum disease) 
(supplemental Table 1). A total of 101 subjects in the CPA 
treated group were included in the assessment; results 
showed significant improvement in the full body disease 
score. Prior to CPA treatment the average disease 
score was 0.65 ± 0.11 (range 0.37-0.95) compared to 
post CPA treatment 0.29 ± 0.10 (range 0.1-0.53) (P < 
0.001). This measure correlates well with both the ROM 
measures (Table 6 and the changes observed in the 
quartiles post CPA treatment in Table 5).
DISCUSSION
It is widely accepted that the adhesions that cause SBO 
and symptomology in subjects are often caused due 
to prior abdominal or pelvic surgery[10,46]. This study is 
the first controlled study of a specific physical therapy 
protocol known as the Clear Passage Approach (CPA) 
in subjects with a history of SBO. The results of this 
study are very similar to those reported in an earlier 
uncontrolled efficacy study and case reports using 
the CPA to treat subjects with recurring SBO[35]. In all 
measures, the subjects treated with the CPA experienced 
significant improvements as compared to experiences 
Table 5  Quartile assignment for each domain of the Small Bowel Obstruction Questionnaire for all groups and questionnaire time 
points
Baseline 90 d/90 d post treatment
Diet Pain GI QOL Medication Diet Pain GI QOL Medication
Quartiles for control subjects
   Normal 44 16 24   4 100 34 24 26 12 100
   Mild 54 76 79 37 27 61 80 86 22   24
   Moderate 24 41 29 59   9 30 29 22 78   12
   Severe 14   3   4 36   0 11   3   2 24     0
Quartiles for CPA treated subjects
   Normal 24 47 50 22 71 52 74 74 60    82
   Mild 21 27 34 39   7 26 22 20 26     3
   Moderate 35 24 15 27 25 16   6   8   9    18
   Severe 23   5   4 15   0   9   1   1   8     0
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before CPA treatment and when compared to untreated 
controls. Manual physical therapy can provide adjunct 
therapy for known adhesions where there is no other 
available therapy proven to decrease recurrent SBO or 
to treat pain associated with adhesive disease. Unlike 
surgical procedures, adhesions do not appear to occur 
after treatment with the CPA[28]. 
Because treatment group participants had more 
complex histories and symptoms, their improvements 
likely had more of an impact on daily function than 
subjects in the control group. The results from this study 
suggest that the CPA can be used to treat adhesions 
and scar adherence safely in the recurrent SBO subject 
population, demonstrating significant improvements 
in overall pain, severity of pain, QOL and number of 
episodes of SBO as compared to untreated subjects. 
Further, subjects who were previously concerned about 
having another SBO episode reported a significant 
decrease in that concern three months after treatment. 
In addition, the cost savings from using a relatively 
inexpensive outpatient treatment in place of surgery to 
prevent future obstruction, hospitalization and surgery is 
worthy of consideration.
Based upon changes in range of motion and disease 
scores, it is inferred that tissue and organ mobility was 
improved as the subjects demonstrated an increased 
range of motion in active movement tests. Improvements 
in range of motion allowed subjects to perform daily tasks 
more easily and contributed positively to their overall QOL.
The limitations of this study include the lack of rando-
mization and sham treatment group. A sham treatment 
is challenging to accomplish in a study such as this where 
the treatment is 20 h of manual therapy over the course 
of one week. Indirect measures used to assess adhesions 
in the subjects including improvement in self-reported 
symptoms; ROM and objective disease scoring were used 
as outcome measures. While these measures are indirect, 
all correlated well with the post CPA treatment experiences 
and the decreased number of SBOs and surgeries in the 
treatment group, compared to the control group.
Today when a patient is discharged after non-surgical 
(or surgical) management of adhesive SBO, there is no 
therapy that can be prescribed to help reduce recurrence. 
Further, the quality of life for patients who have under-
gone SBO, with or without surgery, is often greatly com-
promised. Repeat surgery for SBO is widely regarded 
as a primary cause of recurring SBO. This technique 
appears to delay or obviate surgery for many patients 
who have undergone the trauma of SBO, at a fraction 
of the cost of surgery. It offers a therapy where none 
is currently available. The CPA therapy appears to be a 
viable conservative option for patients who previously 
were told that there was nothing that they could do to 
reduce their chances of recurrent SBO. 
ARTICLE HIGHLIGHTS
Research background 
Manual physiotherapy (mPT), called “manual physical therapy” in the United 
States, has been used to treat a wide variety of adhesive conditions including 
burns, adhesive capsulitis, radiculopathy, pain and the lessening of scars. In 
pilot studies, independent radiologic reports showed that the Clear Passage 
Approach (CPA), a specialized mPT performed in an outpatient setting, 
cleared bowel stricture and obstruction, obviating the need for planned surgical 
adhesiolysis and bowel resection. In case control and efficacy studies, CPA 
demonstrated effectiveness decreasing adhesions and pain, and improving 
quality of life (QOL) in subjects with recurrent small bowel obstruction (SBO). 
Surgery is often cited as a primary cause of recurrent SBO due to the 
formation of post-operative adhesions. If a non-invasive outpatient therapy can 
decrease recurrent SBO and reduce the need for additional surgeries, it can 
improve quality of life for patients, with lower risk and decreased cost. 
Research motivation
Adhesions that form after surgery present major problems for physicians and 
their patients. Surgeons note that adhesion barriers and gels are not always 
effective at preventing recurrent adhesions. The opportunity to delay or prevent 
post-surgical adhesions that can cause pain and recurring bowel obstruction 
is profound for patients. Many people live in fear that another major surgery or 
death could occur at any time, due to a recurrent obstruction.
Research objectives 
The study has two main objectives: (1) To determine whether a manual 
physiotherapy can lower the rate of repeat SBO in patients who have 
undergone prior adhesive bowel obstructions and surgeries; and (2) to examine 
whether the therapy can improve the quality of life of these patients, using a 
validated test.
Range of motion 
measure (normal)
Pretreatment (n  = 103) 
mean (SD)
Post treatment (n  = 103) 
mean (SD)
Raw P  value Multiplicity 
adjusted P  value
Lower confidence 
bound
Upper confidence 
bound
Number with normal ROM Number with normal ROM
Flexion (80) 76.9 (19.4) 82.5 (15.1) < 0.001 0.010 -10.4 -0.7
48 74
Extension (25) 25.2 (13.7) 29.9 (11.8) < 0.001 < 0.001   -7.8 -1.5
45 77
Left side bending (45) 38.0 (10.3) 42.6 (8.7) < 0.001 < 0.001   -7.2 -2.1
37 59
Right side bending (45) 38.8 (12.2) 43.4 (8.7) < 0.001 < 0.001   -7.4 -1.8
47 62
Left rotation (45) 37.0 (14.8) 44.2 (14.4) < 0.001 < 0.001 -10.4    -4
23 47
Right rotation (45) 39.3 (13.6) 45.5 (12.3) < 0.001 < 0.001   -9.5 -2.9
44 70
ROM: Range of motion.
Table 6  Range of motion averages in Clear Passage Approach treated subjects prior to and post Clear Passage Approach treatment
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Research methods
This is a controlled phase two study in which 103 subjects with a history of 
recurrent adhesive SBO were treated with a manual physical therapy called 
the CPA. The focus of the therapy was to decrease adhesive crosslinking 
in abdominopelvic viscera. Pre- and post-therapy data measured recurring 
obstructions and quality of life using a validated test sent 90 d after therapy. 
Results were compared to 136 untreated control subjects who underwent the 
same measurements, but who did not receive any therapy. Until this method 
was developed, physical therapy has never been investigated as a course to 
treat recurring SBO.
Research results
Despite histories of more prior hospitalizations, obstructions, surgeries, and 
years impacted by bowel issues, the 103 CPA-treated subjects reported 
a significantly lower rate of repeat SBO than 136 untreated controls (total 
obstructions P = 0.0003; partial obstructions P = 0.0076). Subjects treated with 
the therapy demonstrated significant improvements in five of six total domains 
in the validated Small Bowel Obstruction Questionnaire (SBO-Q). Domains of 
diet, pain, gastrointestinal (GI) symptoms, quality of life (QOL) and pain severity 
when compared to post CPA treatment were significantly improved (P < 0.0001). 
The medication domain was not changed in the CPA treated group (P = 0.176).
Numerous studies examine the use of mPT to decrease adhesions and 
pain, and to improve function for conditions in various parts of the body. Pilot 
studies that examine the use of CPA include independent radiographs of 
cleared bowel obstruction. In a 10-year retrospective study of using CPA to treat 
adhesion-related female infertility (n = 1392), CPA opened blocked fallopian 
tubes in 60.85% (143/235) of women diagnosed with total tubal occlusion. In 
a recent study, mPT was shown to disrupt bowel adhesions in a rat model. 
This is the first controlled study of using a manual physiotherapy to decrease 
adhesions in the bowel.
The availability of the therapy is presently limited to private outpatient 
clinics in the United States and United Kingdom where therapists have been 
fully trained and certified in the CPA.
Research conclusions
A manual physiotherapy significantly improved quality of life and significantly 
decreased the rate of re-occlusion for patients with a history of SBO. Performed 
in an outpatient setting, the non-invasive therapy significantly reduced repeat 
obstructions. In addition, the physical therapy has a much lower risk and cost 
than hospitalization or surgery.
The study proposes that manual physiotherapy, which is commonly used 
to decrease adhesions in a variety of conditions, may be useful to decrease 
adhesions in the bowel. As such, it may delay or prevent recurring SBO. 
This study noted that: (1) Post-surgical adhesions are frequently cited 
as the primary cause of SBO; (2) average costs in the United States for 
adhesiolysis and SBO are $65955 and $114175, respectively; (3) average 
hospital stays for adhesiolysis and SBO are 8.4 d and 14.2 d, respectively; (4) 
costs for a novel non-surgical physiotherapy to address adhesions and SBO are 
less than $7000; (5) Subjects treated with the therapy reported a significantly 
lower rate of repeat SBO than the untreated controls (total obstructions P = 
0.0003; partial obstructions P = 0.0076); (6) subjects treated with the therapy 
demonstrated significant improvements in five of six total domains in the 
validated SBO-Q; (7) statistical analysis showed a significant increase in all 
six measures of trunk range of motion (flexion, extension, left and right side 
bending, left and right rotation.)
A manual physiotherapy significantly decreased the rate of recurrent small 
bowel obstruction (SBO) and improved quality of life for patients with a history 
of prior SBO. Based on the decreased number of recurring obstructions and the 
measurable improvements in trunk range of motion, this manual physiotherapy 
can significantly improve outcomes and quality of life for patients who undergo 
abdominal or pelvic surgery to treat adhesions or SBO.
This study proposes the use of a specialized manual physiotherapy, the 
CPA, to delay or prevent recurring SBO. This study confirmed and quantified 
hypotheses from earlier pilot studies that CPA could increase QOL, delay or 
prevent recurring SBO, and delay or obviate the need for additional surgery 
for patients with recurring SBO, with less risk and a lower cost than the 
present model. The major implication for clinical practice is that physicians, 
who are often stymied by the frequent recurrence of adhesions and SBO 
following abdominal surgery or resection, now have a less risky and less costly 
alternative to repeat surgery. 
Research perspectives
There is a place for a multi-disciplinary approach to a vexing problem for 
surgeons - the recurrence of adhesions and SBO following abdominal surgery 
or pelvic surgery. We hope to be able to quantify further the degree to which 
CPA can decrease the recurrence of SBO, and the need for repeat surgeries. 
A prospective controlled study with closely matched study groups could be 
performed with the CPA method vs sham physiotherapy.
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